Skip to main content
Patient-Centered Outcomes Research Institute
Patient-Centered Outcomes Research Institute
  • Blog
  • Newsroom
  • Find It Fast
  • Help Center
  • Subscribe
  • Careers
  • Contact Us

PCORI

Patient-Centered Outcomes Research Institute

Search form

  • About Us
    Close mega-menu

    About Us

    • Our Programs
    • Governance
    • Financials and Reports
    • Procurement Opportunities
    • Our Staff
    • Our Vision & Mission
    • Contact Us

    Fact Sheets: Learn More About PCORI

    Download fact sheets about out work, the research we fund, and our programs and initiatives.

    Find It Fast

    Browse through an alphabetical list of frequently accessed and searched terms for information and resources.

    Subscribe to PCORI Email Alerts

    Sign up for weekly emails to stay current on the latest results of our funded projects, and more.

  • Research & Results
    Close mega-menu

    Research & Results

    • Explore Our Portfolio
    • Research Fundamentals
    • Research Results Highlights
    • Putting Evidence to Work
    • Peer Review
    • Evidence Synthesis
    • About Our Research

    Evidence Updates from PCORI-Funded Studies

    These updates capture highlights of findings from systematic reviews and our funded research studies.

    Journal Articles About Our Funded Research

    Browse through a collection of journal publications that provides insights into PCORI-funded work.

    Explore Our Portfolio of Funded Projects

    Find out about projects based on the health conditions they focus on, the state they are in, and if they have results.

  • Topics
    Close mega-menu

    Topics

    • Addressing Disparities
    • Arthritis
    • Asthma
    • Cancer
    • Cardiovascular Disease
    • Children's Health
    • Community Health Workers
    • COVID-19
    • Dementia and Cognitive Impairment
    • Diabetes
    • Kidney Disease
    • Medicaid
    • Men's Health
    • Mental and Behavioral Health
    • Minority Mental Health
    • Multiple Chronic Conditions
    • Multiple Sclerosis
    • Obesity
    • Older Adults' Health
    • Pain Care and Opioids
    • Rare Diseases
    • Rural Health
    • Shared Decision Making
    • Telehealth
    • Transitional Care
    • Veterans Health
    • Women's Health

    Featured Topic: Women's Health

    Learn more about the projects we support on conditions that specifically or more often affect women.

  • Engagement
    Close mega-menu

    Engagement

    • The Value of Engagement
    • Engagement in Health Research Literature Explorer
    • Influencing the Culture of Research
    • Engagement Awards
    • Engagement Resources
    • Engage with Us

    Engagement Tools and Resources for Research

    This searchable peer-to-peer repository includes resources that can inform future work in patient-centered outcomes research.

    Explore Engagement in Health Literature

    This tool enables searching for published articles about engagement in health research.

    Research Fundamentals: A New On-Demand Training

    It enables those new to health research or patient-centered research to learn more about the research process.

  • Funding Opportunities
    Close mega-menu

    Funding Opportunities

    • What & Who We Fund
    • What You Need to Know to Apply
    • Applicant Training
    • Merit Review
    • Awardee Resources
    • Help Center

    PCORI Funding Opportunities

    View and learn about the newly opened funding announcements and the upcoming PFAs in 2021.

    Tips for Submitting a Responsive LOI

    Find out what PCORI looks for in a letter of intent (LOI) along with other helpful tips.

    PCORI Awardee Resources

    These resources can help awardees in complying with the terms and conditions of their contract.

  • Meetings & Events
    Close mega-menu

    Meetings & Events

    • Upcoming
    • Past Events

    January 2021 Board of Governors Meeting

    The Board approved funding for a new research study relating to kidney health and a new funding allocation for PCORnet. Learn more

    Confronting COVID-19: A Webinar Series

    Learn more about the series and access recordings and summary reports of all six sessions.

    2020 PCORI Annual Meeting

    Watch recordings of all sessions, and view titles and descriptions of the posters presented at the virtual meeting.

You are here

  • Research & Results
  • Explore Our Portfolio
  • Helping Doctors Prescribe Medicine to...

Helping Doctors Prescribe Medicine to Prevent Febrile Neutropenia for Patients Getting Chemotherapy -- The TrACER Study

Sign Up for Updates to This Study  

Project Summary  

PCORI has identified the need for large studies that look at real-life questions faced by diverse patients, caregivers, and clinicians. To address this need, PCORI launched the Pragmatic Clinical Studies initiative in 2014. Pragmatic clinical studies allow for larger-scale studies with longer timelines to compare the benefits and harms of two or more approaches known to be effective for preventing, diagnosing, treating, or managing a disease or symptom. They focus on everyday care for a wide range of patients. This research project is one of the studies PCORI awarded as part of this program.

This research project is in progress. PCORI will post the research findings on this page within 90 days after the results are final.

What is the research about?

Some patients who get chemotherapy come down with a serious health problem called febrile neutropenia, which involves having a fever and a low number of a type of white blood cells. Having a low number of white blood cells puts patients at risk for infection. Different types of chemotherapy put patients at different levels of risk for febrile neutropenia. When patients get chemotherapy that creates a high risk of febrile neutropenia, a type of medicine called colony-stimulating factor can help prevent it. When patients get chemotherapy that creates a low risk of this health problem, they do not need this medicine. It’s unclear whether the medicine helps patients who get chemotherapy that creates a medium risk of this health problem.

In this study, researchers are testing ways of giving doctors information to help them prescribe colony-stimulating factor medicine to the right patients.

Many doctors use computer systems to order prescriptions. The researchers want to know whether doctors follow national guidelines about when to prescribe colony-stimulating factor if their prescription order system automatically recommends it for patients who get chemotherapy that creates increased risk. They also want to find out how effective the medicine is for patients according to the risk level that their chemotherapy creates.

Who can this research help?

Results from this study can help doctors decide whether to prescribe colony-stimulating factor medicine for patients getting chemotherapy that creates a medium risk of febrile neutropenia. Results can also help healthcare leaders decide whether changing their prescription order system to make it easier for doctors to follow national guidelines will help chemotherapy patients get medicine that will help them, and spare patients who don’t need it the costs and potential side effects.

What is the research team doing?

The research team is recruiting 3,960 patients at 45 cancer clinics. They are assigning each clinic to one of four groups:

  • Group 1 includes clinics that already use a prescription order system to help doctors prescribe colony-stimulating factor medicine according to guidelines. The doctors use the system to order medicine as they usually would. Clinics that do not already use this type of order system are being assigned to group 2, 3, or 4 by chance.
  • In group 2 clinics, doctors order medicine as they usually would, without use of a prescription order system.
  • In group 3 clinics, when doctors order high- or medium-risk chemotherapy, a study-provided prescription order system recommends that patients get the medicine.
  • In group 4 clinics, doctors use the study-provided prescription order system, but it recommends the medicine only for patients getting high-risk chemotherapy, not for patients getting medium-risk chemotherapy.

This study includes adults aged 18 and older with breast, lung, or colorectal cancer who are getting chemotherapy at one of the 45 study clinics and who speak English or Spanish. Patients complete surveys about their quality of life, the cost of treatment, and what they know about the risks and benefits of colony-stimulating factor medicine. Patients complete the surveys when they enroll in the study, after their first cycle of chemotherapy, and six months later.

Researchers are looking at how often doctors follow recommendations from the prescription order systems for prescribing colony-stimulating factor medicine. The researchers are also looking at patient experiences, including how often patients develop fever and a low number of white blood cells, whether they use antibiotics, whether they take the medicine as prescribed by their doctor, whether they go to the emergency room, how often they go to the hospital, whether they finish their planned chemotherapy, and whether they die from any cause. .

Patients, cancer doctors and nurses, pharmacists, insurance-plan leaders, policy makers, and clinic leaders are involved in this study. They are offering input on research questions, the study design, ways to enroll patients in the study, and sharing information about the study with the public.

Research methods at a glance

Design Element Description
Study Design Randomized controlled trial
Population Adults aged 18 and older with breast, non-small cell lung, or colorectal cancer who are receiving chemotherapy at 1 of the participating clinics and speak English or Spanish
Interventions/
Comparators
  • Standardized prescription order system already in use for prescribing prophylactic colony-stimulating factor (group 1, observational cohort)
  • No standardized prescription order system. Patients receive medicine based on clinic’s existing clinical practice guidelines (group 2, primary randomization)
  • Standardized prescription order system; National Comprehensive Cancer Network guideline-based prophylactic colony-stimulating factor (medicine to prevent febrile neutropenia) orders and recommendations for patients undergoing chemotherapy that creates high or low risk of febrile neutropenia (groups 3 and 4, primary randomization)
  • Prophylactic colony-stimulating factor medicine recommendation for patients undergoing chemotherapy that creates medium risk of febrile neutropenia (group 3, secondary randomization)
  • No prophylactic colony-stimulating factor medicine for patients undergoing chemotherapy that creates medium risk of febrile neutropenia (group 4, secondary randomization)
Outcomes

Use of prophylactic colony-stimulating factor medicine that is consistent with guidelines, rate of febrile neutropenia, prophylactic and febrile neutropenia-related antibiotic use, emergency room visits and hospitalizations related to febrile neutropenia, mortality, health-related quality of life, out-of-pocket costs, knowledge of risks, benefits, and costs of prophylactic colony-stimulating factor medicine

Timeframe 12-month follow-up for study outcomes

More on This Project

Related Articles

BMC Medical Research Methodology

Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care

Journal of Comparative Effectiveness Research

A stakeholder-informed randomized, controlled comparative effectiveness study of an order prescribing intervention to improve colony stimulating factor use for cancer patients receiving myelosuppressive chemotherapy: the TrACER study

Project Details

Principal Investigator
Scott D. Ramsey, MD, PhD
Project Status
In progress; Recruiting
Project Title
A Pragmatic Trial to Improve Colony Stimulating Factor Use in Cancer
Board Approval Date
February 2015
Project End Date
April 2022
Organization
Fred Hutchinson Cancer Research Center
Year Awarded
2015
State
Washington
Project Type
Research Project
Health Conditions  
Cancer
Breast Cancer
Lung Cancer
Colorectal Cancer
Infectious Diseases
Intervention Strategies
Drug Interventions
Other Health Services Interventions
Populations
Racial/Ethnic Minorities
Older Adults
Funding Announcement
Pragmatic Clinical Studies to Evaluate Patient-Centered Outcomes
Project Budget
$7,817,799
Study Registration Information
HSRP20153598
NCT02728596
Page Last Updated: 
February 20, 2020

Research & Results

  • Explore Our Portfolio
  • Research Fundamentals
  • Research Results Highlights
  • Putting Evidence to Work
  • Peer Review
  • Evidence Synthesis
  • About Our Research

About Us

  • Our Programs
  • Governance
  • Financials and Reports
  • Procurement Opportunities
  • Our Staff
  • Our Vision & Mission
  • Contact Us

Research & Results

  • Explore Our Portfolio
  • Research Fundamentals
  • Research Results Highlights
  • Putting Evidence to Work
  • Peer Review
  • Evidence Synthesis
  • About Our Research

Engagement

  • The Value of Engagement
  • Engagement in Health Research Literature Explorer
  • Influencing the Culture of Research
  • Engagement Awards
  • Engagement Resources
  • Engage with Us

Funding Opportunities

  • What & Who We Fund
  • What You Need to Know to Apply
  • Applicant Training
  • Merit Review
  • Awardee Resources
  • Help Center

Meetings & Events

January 21
Cycle 1 2021 Broad PFA Applicant Town Hall
February 2
PCORI 2021 and Beyond: Opportunities for Funding and Involvement in Patient-Centered Research
February 9
Board of Governors Meeting: February 9, 2021

PCORI

Footer contact address

Patient-Centered Outcomes
Research Institute

1828 L Street, NW, Suite 900
Washington, DC 20036
Phone: (202) 827-7700 | Fax: (202) 355-9558
[email protected]

Subscribe to Newsletter

Twitter Facebook LinkedIn Vimeo

© 2011-2021 Patient-Centered Outcomes Research Institute. All Rights Reserved.

Privacy Policy | Terms of Use | Trademark Usage Guidelines | Credits | Help Center